ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Monday, November 9, 2015

9:00AM-11:00AM
Abstract Number: 1319
18F-Fluorodeoxyglucose Positron Emission Computer Tomography and Ultrasonography for Assessing Remission in Patients with Rheumatoid Arthritis
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT
9:00AM-11:00AM
Abstract Number: 1681
4-Week Treatment of Rheumatoid Arthritis Patients with the JAK1-Selective Inhibitor Filgotinib (GLPG0634) Changes Lipid Profile with a Preferential Increase in HDL
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II
9:00AM-11:00AM
Abstract Number: 1420
6-Month Change in Pain and Function By Pre-Surgery Pain and Function Among Patients Selected for Total Knee Replacement in the United States
Orthopedics, Low Back Pain and Rehabilitation Poster
9:00AM-11:00AM
Abstract Number: 1474
8-Year Follow-up Study: Differences Between HLA-B27 Positive and Negative Children with Juvenile Idiopathic Arthritis in Finland
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1940
A Circulating Reservoir of Pathogenic-like CD4+ T Cells Shares a Genetic and Phenotypic Signature with the Inflamed Synovial Micro-Environment
T cell Biology and Targets in Autoimmune Disease Poster I
9:00AM-11:00AM
Abstract Number: 1733
A Close Correlation Between Radiologic Progression Severity and Trabecular Bone Loss in Male Patients with Ankylosing Spondylitis
Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II
9:00AM-11:00AM
Abstract Number: 1469
A Comparison of Pain and Disability, and Their Association Between Juvenile Primary Fibromyalgia Syndrome and Pediatric Rheumatic Diseases: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1293
A Comparison of Prenatal Care  in Mothers with and without JIA: Association with Outcomes
Health Services Research Poster (ARHP)
9:00AM-11:00AM
Abstract Number: 1481
A Description of the Transition Aged Population in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1782
a Double-Blind, Randomized, Parallel-Group Study of Hydroxychloroquine on Cutaneous Lupus Erythematosus in Japan
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II
9:00AM-11:00AM
Abstract Number: 1411
A Double-Blind, Randomized, Placebo-Controlled Trial of Mesenchymal Stem Cells for the Treatment of Patients with Full-Thickness Rotator Cuff Tears
Orthopedics, Low Back Pain and Rehabilitation Poster
9:00AM-11:00AM
Abstract Number: 1810
A Five-Year Follow-up of Microvascular Dysfunction and Coronary Artery Disease in SLE: Results from a Community-Based Lupus Cohort
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II
9:00AM-11:00AM
Abstract Number: 1131
A Histone Deacetylase Inhibitor SAHA Induce MCPIP1 Expression and Suppress IL-6 Expression By Upregulating Cebpα Expression and Downregulating the Expression of Mir-9 in Human OA Chondrocytes
Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis
9:00AM-11:00AM
Abstract Number: 1652
A HPLC-SRM-MS Based Method for the Detection of Adherence to Low-Dose Oral Methotrexate
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II
9:00AM-11:00AM
Abstract Number: 1591
A Low Adiponectin Level in Rheumatoid Arthritis Is Associated with Coronary Artery Disease
Rheumatoid Arthritis - Clinical Aspects Poster II
  • 1
  • 2
  • 3
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology